120 related articles for article (PubMed ID: 6329379)
21. The value of the ultrastructural pattern of myeloperoxidase and platelet peroxidase in identification of two blastic cell types during transformation of a chronic myeloproliferative disorder.
Moldoveanu E; Moicean A; Colita A; Halalau F
Haematologia (Budap); 1996; 27(3):135-41. PubMed ID: 14653450
[TBL] [Abstract][Full Text] [Related]
22. Terminal-deoxynucleotidyl-transferase immunofluorescence on bone marrow smears: serial studies on 28 patients.
Miller WM; Stass SA; Schumacher HR; Bollum FJ
Am J Hematol; 1981; 10(1):1-7. PubMed ID: 7020412
[TBL] [Abstract][Full Text] [Related]
23. Acute mixed lineage leukemia: clinicopathologic correlations and prognostic significance.
Mirro J; Zipf TF; Pui CH; Kitchingman G; Williams D; Melvin S; Murphy SB; Stass S
Blood; 1985 Nov; 66(5):1115-23. PubMed ID: 3931724
[TBL] [Abstract][Full Text] [Related]
24. Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia.
Drexler HG; Sperling C; Ludwig WD
Leukemia; 1993 Aug; 7(8):1142-50. PubMed ID: 7688837
[TBL] [Abstract][Full Text] [Related]
25. Detection of myeloperoxidase gene expression in minimally differentiated acute myelogenous leukemia (AML-M0) using in situ hybridization.
Traweek ST; Liu J; Braziel RM; Johnson RM; Byrnes RK
Diagn Mol Pathol; 1995 Sep; 4(3):212-9. PubMed ID: 7493141
[TBL] [Abstract][Full Text] [Related]
26. Serum and plasma myeloperoxidase, elastase and lactoferrin content in acute myeloid leukaemia.
Olsson I; Olofsson T; Ohlsson K; Gustavsson A
Scand J Haematol; 1979 May; 22(5):397-406. PubMed ID: 224448
[TBL] [Abstract][Full Text] [Related]
27. Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia.
Foa R; Casorati G; Giubellino MC; Basso G; Schirò R; Pizzolo G; Lauria F; Lefranc MP; Rabbitts TH; Migone N
J Exp Med; 1987 Mar; 165(3):879-90. PubMed ID: 3102679
[TBL] [Abstract][Full Text] [Related]
28. Terminal deoxynucleotidyl transferase staining in acute leukemia and normal bone marrow in routinely processed paraffin sections.
Orazi A; Cotton J; Cattoretti G; Kotylo PK; John K; Manning JT; Neiman RS
Am J Clin Pathol; 1994 Nov; 102(5):640-5. PubMed ID: 7524307
[TBL] [Abstract][Full Text] [Related]
29. Determination of ultrastructural peroxidases and immunologic membrane markers in the diagnosis of acute leukemias.
Marie JP; Perrot JY; Boucheix C; Zittoun J; Martyre MC; Kayibanda M; Rosenfeld C; Mishal Z; Zittoun R
Blood; 1982 Feb; 59(2):270-6. PubMed ID: 6948582
[TBL] [Abstract][Full Text] [Related]
30. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
[TBL] [Abstract][Full Text] [Related]
31. Myeloperoxidase-deficient polymorphonuclear leucocytes. (II) Longitudinal study in acute myeloid leukaemia, untreated, in remission and in relapse.
Bendix-Hansen K; Nielsen HK
Scand J Haematol; 1983 Jul; 31(1):5-8. PubMed ID: 6306759
[TBL] [Abstract][Full Text] [Related]
32. Identification of acute myeloid leukemia in dogs using flow cytometry with myeloperoxidase, MAC387, and a canine neutrophil-specific antibody.
Villiers E; Baines S; Law AM; Mallows V
Vet Clin Pathol; 2006 Mar; 35(1):55-71. PubMed ID: 16511792
[TBL] [Abstract][Full Text] [Related]
33. Distinct gene alterations with a high percentage of myeloperoxidase-positive leukemic blasts in de novo acute myeloid leukemia.
Kamijo R; Itonaga H; Kihara R; Nagata Y; Hata T; Asou N; Ohtake S; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Naoe T; Kiyoi H; Miyazaki Y
Leuk Res; 2018 Feb; 65():34-41. PubMed ID: 29306105
[TBL] [Abstract][Full Text] [Related]
34. Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21).
Porwit-MacDonald A; Janossy G; Ivory K; Swirsky D; Peters R; Wheatley K; Walker H; Turker A; Goldstone AH; Burnett A
Blood; 1996 Feb; 87(3):1162-9. PubMed ID: 8562943
[TBL] [Abstract][Full Text] [Related]
35. Terminal deoxynucleotidyl transferase positive acute myeloid leukaemia: an association with immature myeloblastic leukaemia.
Parreira A; Pombo de Oliveira MS; Matutes E; Foroni L; Morilla R; Catovsky D
Br J Haematol; 1988 Jun; 69(2):219-24. PubMed ID: 3164631
[TBL] [Abstract][Full Text] [Related]
36. Terminal deoxynucleotidyl transferase expression in acute non-lymphoid leukaemia: an analysis by immunofluorescence.
Bradstock KF; Hoffbrand AV; Ganeshaguru K; Llewellin P; Patterson K; Wonke B; Prentice AG; Bennett M; Pizzolo G; Bollum FJ; Janossy G
Br J Haematol; 1981 Jan; 47(1):133-43. PubMed ID: 7002203
[TBL] [Abstract][Full Text] [Related]
37. Terminal-deoxynucleotidyl transferase (TdT): serial observations on patients with leukemia.
Schumacher HR; Haider Y; Miller WM; Stass SA; Bollum FJ
Am J Med Sci; 1983; 286(3):18-24. PubMed ID: 6356915
[TBL] [Abstract][Full Text] [Related]
38. Immunoperoxidase determination of terminal deoxynucleotidyl transferase in acute leukemia using PAP and ABC methods: experience in 102 cases.
Lanham GR; Melvin SL; Stass SA
Am J Clin Pathol; 1985 Mar; 83(3):366-70. PubMed ID: 3919564
[TBL] [Abstract][Full Text] [Related]
39. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
Robertson PB; Neiman RS; Worapongpaiboon S; John K; Orazi A
Mod Pathol; 1997 Apr; 10(4):277-82. PubMed ID: 9110287
[TBL] [Abstract][Full Text] [Related]
40. Chromatographic forms of terminal deoxynucleotidyl transferase in normal lymphoid cells and in leukemia cells at presentation and relapse.
Bell R; Lillquist A; Abelson H; McCaffrey R
Leuk Res; 1982; 6(6):775-80. PubMed ID: 6984113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
